Latest News in the pharma Industry
Research & Development
Optibrium and Goldfinch Bio sign agreement for StarDrop license
9 May 2017
Goldfinch Bio’s researchers select StarDrop to guide successful drug discovery.
Read more
New buprenorphine wafers could help thousands battling opioid addiction
8 May 2017
When compared with current hard sublingual tablets, the novel formulation dissolved quickly with no increased safety concerns and no demonstrable difference in efficacy.
Read more
SGS Clinical Research announces results of FiH studies using novel virus as experimental challenge agent
4 May 2017
Strain represents one of the common current circulating strains of influenza of a pandemic origin.
Read more
NIH discovery in mice could lead to new class of medications to fight mid-life obesity
3 May 2017
With lower rates of obesity, the researchers say rates of heart disease, diabetes, and other diseases that tend to increase with age, including cancer and Alzheimer’s disease, could fall as well.
Read more
Isogenica introduces next-generation, fully synthetic human Fab antibody fragment library
3 May 2017
Library claimed to offer "the most efficient route to therapeutic antibody lead identification".
Read more
AstraZeneca’s Imfinzi receives FDA accelerated approval for previously treated patients with advanced bladder cancer
2 May 2017
Imfinzi is the cornerstone in an extensive immuno-oncology program across multiple cancer types and stages of disease.
Read more
Concert Pharmaceuticals initiates CTP-543 Phase II trial in alopecia areata
2 May 2017
Trial designed to evaluate the safety and efficacy of CTP-543 after 12 months of dosing with the primary efficacy analysis at week 24.
Read more
Shire and Parion Sciences sign collaborative license agreement to advance P-321 for ophthalmic indications
1 May 2017
P-321 is a Phase II investigational topical treatment for dry eye disease.
Read more
Takeda announces FDA Accelerated Approval of Alunbrig
30 Apr 2017
Alunbrig approved for ALK+ metastatic non-small Cell lung cancer patients who have progressed on or are intolerant to crizotinib.
Read more
Antidepressant may enhance drug delivery to the brain
27 Apr 2017
NIH rat study suggests amitriptyline temporarily inhibits the blood-brain barrier, allowing drugs to enter the brain.
Read more
Regeneron and Sanofi receive FDA approval of a new once-monthly dosing option for Praluent Injection
26 Apr 2017
Monthly dosing schedule now approved in both US and EU.
Read more
Novartis expands global collaboration with Amgen to commercialize first-in-class AMG 334 program in migraine prevention
25 Apr 2017
Novartis and Amgen to co-commercialize AMG 334 (erenumab) in the US; Novartis to gain exclusive rights in Canada,
Read more